Renal, retinal and cardiac changes in type 2 diabetes are attenuated by macitentan, a dual endothelin receptor antagonist
S. Sen, S. Chen, B. Feng, M. Iglarz, S. ChakrabartiVolume:
91
Year:
2012
Language:
english
DOI:
10.1016/j.lfs.2012.03.032
File:
PDF, 1.26 MB
english, 2012